BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3076381)

  • 1. A study on OX39, a murine anti-rat interleukin 2 receptor antibody. A report on receptor binding and effects on allograft survival.
    Jacques Y; Paineau J; Chevalier S; Le Mauff B; Soulillou JP
    Transpl Int; 1988 Jul; 1(2):58-63. PubMed ID: 3076381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of an anti-interleukin 2 receptor monoclonal antibody in rat recipients of a heart allograft, and its use as a rejection marker in gamma scintigraphy.
    Thedrez P; Paineau J; Jacques Y; Chatal JF; Pelegrin A; Bouchaud C; Soulillou JP
    Transplantation; 1989 Sep; 48(3):367-71. PubMed ID: 2675394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between OX39, a mouse monoclonal antibody, and rat interleukin-2 receptors in vitro and in vivo.
    Jacques Y; Paineau J; Chevalier S; Le Mauff B; Soulillou JP
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):38-40. PubMed ID: 2459822
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 2 receptor in rat heart allograft rejection.
    Bouchot O; Anegon I; Romaniuk A; Jacques Y; Paineau J; Soulillou JP
    Transplantation; 1989 Dec; 48(6):918-22. PubMed ID: 2595779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of anti-interleukin 2 monoclonal antibody treatment on the survival of rat cardiac allograft.
    Sakagami K; Ohsaki T; Ohnishi T; Saito S; Matsuoka J; Orita K
    J Surg Res; 1989 Mar; 46(3):262-6. PubMed ID: 2646474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody treatment (anti-CD4 and anti-interleukin-2 receptor) combined with cyclosporin A has a positive but not simple dose-dependent effect on rat renal allograft survival.
    Steinbrüchel DA; Koch C; Kristensen T; Kemp E
    Scand J Immunol; 1991 Nov; 34(5):627-33. PubMed ID: 1947798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies identify three epitope clusters on the mouse p55 subunit of the interleukin 2 receptor: relationship to the interleukin 2-binding site.
    Moreau JL; Nabholz M; Diamantstein T; Malek T; Shevach E; Thèze J
    Eur J Immunol; 1987 Jul; 17(7):929-35. PubMed ID: 2440696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prolonged monoclonal antibody administration on cardiac allograft survival in the rat.
    Roza AM; Kimura H; Markmann J; Naji A
    Scand J Immunol; 1989 Sep; 30(3):333-8. PubMed ID: 2675304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic epitopes of the p55 chain of the IL-2 receptor. Relationships to high-affinity IL-2 binding and modulation of the p55 chain.
    Wong JT; Schott E; Sabga EM; Kielpinski GG; Colvin RB
    Transplantation; 1990 Mar; 49(3):587-96. PubMed ID: 1690471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cluster-function relationship of rat-antimouse P55 IL-2 receptor monoclonal antibodies. In vitro studies of the CTL-L2 mouse cell line and in vivo studies in a delayed-type hypersensitivity model in mice.
    Dantal J; Jacques Y; Soulillou JP
    Transplantation; 1991 Jul; 52(1):110-5. PubMed ID: 1858138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-receptors: interrelationship between 33B3.1, anti-Tac, and IL2 binding sites.
    Le Mauff B; Gascan H; Olive D; Moreau JF; Mawas C; Soulillou JP; Jacques Y
    Hum Immunol; 1987 May; 19(1):53-68. PubMed ID: 3034838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
    Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
    Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse high affinity IL 2 receptor complex. I. Evidence for a third molecule, the putative gamma-chain, associated with the alpha- and/or beta-chain of the receptor.
    Herrmann T; Diamantstein T
    Immunobiology; 1987 Sep; 175(3):145-58. PubMed ID: 3119468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal anti-IL2-receptor in organ transplantation.
    Soulillou JP; Jacques Y
    Transpl Int; 1989 Apr; 2(1):46-52. PubMed ID: 2669805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic action of monoclonal antibodies directed at p55 and p75 chains of the human IL-2-receptor.
    Audrain M; Boeffard F; Soulillou JP; Jacques Y
    J Immunol; 1991 Feb; 146(3):884-92. PubMed ID: 1988501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogold labeling of the low-affinity (55 kd) IL2 receptor on the surface of IL2 receptor-bearing cultured cells and mitogen-activated peripheral blood lymphocytes.
    McGroarty RJ; Mills GB; de Harven E
    J Leukoc Biol; 1990 Sep; 48(3):213-9. PubMed ID: 2391447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of acute allograft rejection in rat heart transplantation: flowcytometric monitoring of interleukin 2 receptor expression on CD8 positive lymphocytes.
    Kohmoto T; Arai S; Senoo Y; Teramoto S
    Acta Med Okayama; 1993 Jun; 47(3):145-50. PubMed ID: 8379342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
    Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indefinite allograft survival induced by the combination of multiple donor-specific transfusions, cyclosporine, and an anti-T cell monoclonal antibody in a protocol relevant to cadaveric organ transplantation. The importance of prolonged posttransplant cyclosporine coverage.
    Tchervenkov JI; Cofer BR; Davies C; Alexander JW
    Transplantation; 1995 Mar; 59(6):821-4. PubMed ID: 7701575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.